Oliver is Co-Founder and Chief Scientific Officer at BIOS, one of the 3 most advanced “bio-electronic” companies worldwide, building technology to connect human nervous system with AI-enabled computer systems for monitoring, diagnostic and therapeutic applications.
Oliver has always had a vision that the human body could be repaired or made better through augmentative technology and how that can be used to improve people’s lives. He studied for his PhD at the University of Cambridge in Bioengineering, working in the world-renowned Nanoscience Centre. He specializes in biointerfaces and tissue engineering to allow technology to be fused with the body. Oliver was named to Forbes 30 Under 30 2018.